Content about HANOVER

March 13, 2014

Snyder's of Hanover has launched new Pretzel Spoonz, a double-ended, spoon-shaped pretzel designed for scooping up dips, cheese and spreads.

HANOVER, Pa. — Snyder's of Hanover has launched new Pretzel Spoonz, a double-ended, spoon-shaped pretzel designed for scooping up dips, cheese and spreads.

Pretzel Spoons can be enjoyed in limitless combinations, the company said. The new product is now available nationwide and carries a retail price of around $3.69 for a 12-oz. bag.

March 6, 2014

Nabisco's Brown Rice Triscuit line is expanding to include Brown Rice Triscuit Thin Crisps, which the company said is a new approach to the classic wheat flavor and texture.

EAST HANOVER, N.J. — Nabisco's Brown Rice Triscuit line is expanding to include Brown Rice Triscuit Thin Crisps, which the company said is a new approach to the classic wheat flavor and texture.

The new snack is available in three flavors: Sour Cream & Chive, Wasabi & Soy Sauce and Cinnamon Sugar. Brown Rice Triscuit Thin Crisps are baked with 100% whole-grain brown rice and whea, and pack 23 g of whole grains per 30 g serving.

Consumers can find them at retailers nationwide for a suggested retail price of $3.69 for a 7.6-oz. box.

January 28, 2014

Snyder's of Hanover is adding Korn Krunchers, a new line of baked and seasoned corn snacks, to its lineup of products.

HANOVER, Pa. — Snyder's of Hanover is adding Korn Krunchers, a new line of baked and seasoned corn snacks, to its lineup of products. The snack is offered in three flavors: Korn Krunchers Barbeque, Korn Krunchers Nacho Grande and Korn Krunchers Hot Chili Lime.

November 11, 2013

As many as 56% of Americans who suffer from a cough or cold are still working out at the gym, jumping on public transportation and liberally shaking hands, according to a Mondelez survey in support of its Halls brand.

EAST HANOVER, N.J. — As many as 56% of Americans who suffer from a cough or cold are still working out at the gym, jumping on public transportation and liberally shaking hands, according to a Mondelez survey in support of its Halls brand. And 43% of Americans continue to go to work when they have a cough or cold. 

And it's not just sick people with unhealthy habits. According to the survey, 23% of healthy Americans make no effort to stay away from cough and cold sufferers.

November 6, 2013

Nabisco's Wheat Thins Holiday will hit store shelves nationwide this week.

EAST HANOVER, N.J. — Nabisco's Wheat Thins Holiday will hit store shelves nationwide this week.

The limited-edition snack has the same 100% toasted whole grain, but will feature festive imprints — a snowflake, gingerbread man, bell and candy cane — that will provide additional holiday cheer.

The suggested retail price is $3.69 for a 8.5-oz. box.
 

August 21, 2013

Nabisco announced a new gluten-free, baked snack made with rice.

EAST HANOVER, N.J. — Nabisco announced this week a new gluten-free, baked snack made with rice.

Rice Thins are a light and crispy baked snack. Rice is baked until crisp, resulting in a light texture and irresistable crunch, the company stated.

Rice Thins are available in three flavors: White Rice Original, Brown Rice Sea Salt and Pepper and Brown Rice White Cheddar.

Rice Thins have a suggested retail price of $3.69 per box. They are available this month at retailers nationwide.

June 21, 2013

Stride gum today announced the release of its iOS game, "Gumulon," a new mobile app game controlled by chewing.

EAST HANOVER, N.J. — Stride gum today announced the release of its iOS game, "Gumulon," a new mobile app game controlled by chewing.

Using the front-facing camera available on select mobile devices, players use their mouths to completely control the intergalactic game play — when you chew, the main character, Ace, jumps. This advanced chew-tracking software was developed specifically for "Gumulon."

May 10, 2013

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

April 4, 2013

Triscuit announced a new line of crackers that adds brown rice to its traditional wheat cracker.

EAST HANOVER, N.J. — Triscuit announced this week a new line of crackers that adds brown rice to its traditional wheat cracker.

New Brown Rice Triscuit crackers are made with 100% whole grain brown rice and wheat, and pieces of sweet potato and red beans mixed in. Brown Rice Triscuit crackers contain 21 g of whole grain per 29 g serving. The new line of crackers does not contain high fructose corn syrup, hydrogenated oil, cholesterol or artificial flavors.

Brown Rice Triscuit crackers are available in five flavors:

March 25, 2013

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

Swiss drug maker Novartis announced the approval of Tobi Podhaler (tobramycin inhalation powder) for managing cystic fibrosis patients with Pseudomonas aeruginosa, or Pa bacteria, in the lungs.

February 19, 2013

Honey Maid announced the launch of the Made Co. initiative, a unique contest series through which kids ages 6 years to 12 years will have the chance to win opportunities to have their ideas brought to life with the help of industry experts. The launch coincides with a series of TV commercials for the brand's newest item, Honey Maid Grahamfuls snack crackers.

EAST HANOVER, N.J. — Today, Honey Maid announced the launch of the Made Co. initiative, a unique contest series through which kids ages 6 to 12 years will have the chance to win opportunities to have their ideas brought to life with the help of industry experts. Made Co. was developed to encourage kids to cultivate their imagination and creativity, and inspire them to make things. The launch of the Made Co. initiative coincides with a series of TV commercials for the brand's newest snack, Honey Maid Grahamfuls filled crackers.

February 4, 2013

Following a global celebration of its 100th birthday, Oreo launched its latest marketing campaign "Cookie vs. Creme," during America's biggest football game.

EAST HANOVER, N.J. — Following a global celebration of its 100th birthday, Oreo launched its latest marketing campaign "Cookie vs. Creme," during America's biggest football game.

The premiere of Oreo "Whisper Fight," which is the brand's first time advertising during the Super Bowl, kicked off a two-month program that focuses on the long-standing disagreement dividing Oreo fans — which part of an Oreo is the best, the cookie or the creme?

December 17, 2012

The Food and Drug Administration has approved a new drug to treat a rare but serious endocrine disorder.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new drug to treat a rare but serious endocrine disorder.

Swiss drug maker Novartis announced the approval of Signifor (pasireotide), an injectable drug for treating Cushing's disease in adults for whom pituitary surgery is not an option or has not been curative. Novartis said Signifor was the first drug to be approved in the United States that addresses the disease's underlying mechanism.

November 8, 2012

A Food and Drug Administration expert panel has voted unanimously in favor of approval for a Novartis drug for a rare endocrine disorder.

EAST HANOVER, N.J. — A Food and Drug Administration expert panel has voted unanimously in favor of approval for a Novartis drug for a rare endocrine disorder.

September 6, 2012

A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.

EAST HANOVER, N.J. — A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.

August 17, 2012

Kraft’s Honey Maid brand has launched Grahamfuls, a line of filled graham crackers. The new snack comes in three flavors: Peanut Butter, Peanut Butter and Chocolate, and Banana Vanilla Crème.

EAST HANOVER, N.J. — Kraft’s Honey Maid brand has launched Grahamfuls, a line of filled graham crackers. The new snack comes in three flavors: Peanut Butter, Peanut Butter and Chocolate, and Banana Vanilla Crème. Honey Maid Grahamfuls are made with honey and 100% whole grain, offering 10 g of whole grain per serving. They do not contain high fructose corn syrup or artificial flavorings and are a good source of calcium. Suggested retail for a box of eight individually wrapped Grahamfuls is $4.19.

August 13, 2012

An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.

EAST HANOVER, N.J. — An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.

A phase-3 study published in the American Journal of Transplantation found that patients taking RAD001 (everolimus) with a reduced dose of Astellas' Prograf (tacrolimus) experienced equal efficacy and superior kidney function to patients taking Prograf alone.

August 13, 2012

Oreo is at the halfway point of its 100-day campaign that aims to illustrate moments that are making history today through the eyes of the brand.

EAST HANOVER, N.J. — Oreo is at the halfway point of its 100-day campaign that aims to illustrate moments that are making history today through the eyes of the brand.

July 23, 2012

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new use for a Novartis cancer drug.

The drug maker said Friday that the FDA had approved Afinitor (everolimus) combined with exemestane for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer who have failed treatment with letrozole or anastrozole.

April 27, 2012

A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

EAST HANOVER, N.J. — A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

The FDA approved Afinitor (everolimus) tablets for treating the tumors, known as renal angiomyolipomas, in adults with TSC who don't require surgery. The drug already was approved to treat brain tumors known as subependymal giant cell astrocytoma, or SEGA, in patients with TSC.

April 18, 2012

Planters has partnered with a magazine to launch a new snack aimed at men.

EAST HANOVER, N.J. — Planters has partnered with a magazine to launch a new snack aimed at men.

Planters and Men's Health announced the debut of Planters NUT-rition Men's Health Recommended Mix, a blend of almonds, peanuts and pistachios that contains 6g of protein and six vitamins and minerals per 1-oz. serving. The venture marks the first time Men's Health has partnered with a snack brand, the magazine's publisher, Ronan Gardiner, said.

March 20, 2012

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

EAST HANOVER, N.J. — Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

Novartis Pharmaceuticals, the U.S. division of the Swiss drug manufacturer, announced the launch of Arcapta Neohaler (indacaterol inhalation powder) in the 75-mcg strength. The Food and Drug Administration approved the drug last July.

August 2, 2011

The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

Novartis Pharmaceuticals announced the FDA's approval of Gilenya (fingolimod) for the reduction of T1 gadolinium-enhancing lesions, areas of inflammation in the central nervous system that mark disease activity in people with MS.

July 20, 2011

Stride spokesman and sports icon Shaun White has helped the gum brand boost its portfolio with a new product.

EAST HANOVER, N.J. — Stride spokesman and sports icon Shaun White has helped the gum brand boost its portfolio with a new product.

New Stride Whitemint marks the brand's first-ever custom-designed, custom-created pack, the company said, adding that White helped select the intense mint flavor and was involved in the creation of the gum's package graphics.

As the brand's spokesman, White will participate in a Stride Whitemint TV ad spot this fall, as well as a variety of promotional activities related to the new gum.

June 22, 2011

Kraft Foods is boosting its marketing efforts for its Stride gum brand with a new campaign.

EAST HANOVER, N.J. — Kraft Foods is boosting its marketing efforts for its Stride gum brand with a new campaign.